{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:42:06Z","timestamp":1789188126186,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.neuint.2007.12.001","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T20:06:02Z","timestamp":1197317162000},"page":"1125-1133","source":"Crossref","is-referenced-by-count":46,"title":["N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice"],"prefix":"10.1016","volume":"52","author":[{"given":"Rena C.","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Kasperzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2007.12.001_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-Butyldeoxynojirimycin, in vitro and in vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2007.12.001_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","article-title":"Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease","volume":"16","author":"Andersson","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2007.12.001_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0003-2697(78)90373-1","article-title":"High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species","volume":"89","author":"Ando","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/01.wnl.0000194225.78917.de","article-title":"Substrate reduction therapy in the infantile form of Tay\u2013Sachs disease","volume":"66","author":"Bembi","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2007.12.001_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1471-4159.1998.70020871.x","article-title":"Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryo","volume":"70","author":"Brigande","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1471-4159.2004.02457.x","article-title":"Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease","volume":"90","author":"Buccoliero","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1568026033452483","article-title":"Therapeutic applications of imino sugars in lysosomal storage disorders","volume":"3","author":"Butters","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1098\/rstb.2003.1278","article-title":"Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders","volume":"358","author":"Butters","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuint.2007.12.001_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01770290","article-title":"Biosynthesis of brain gangliosides","volume":"4","author":"Caputto","year":"1974","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1357-4310(98)01227-1","article-title":"Biology and potential strategies for the treatment of GM2 gangliosidoses","volume":"4","author":"Chavany","year":"1998","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.neuint.2007.12.001_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2007.12.001_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the imino sugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2007.12.001_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jnr.20798","article-title":"Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice","volume":"83","author":"Denny","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2007.12.001_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2007.12.001_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib16","series-title":"Genetic Metabolic Disease: Diagnosis and Pre-natal Analysis","author":"Galjaard","year":"1980"},{"key":"10.1016\/j.neuint.2007.12.001_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semcdb.2004.03.003","article-title":"The pathogenesis of glycosphingolipid storage disorders","volume":"15","author":"Ginzburg","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuint.2007.12.001_bib18","doi-asserted-by":"crossref","first-page":"40262","DOI":"10.1074\/jbc.M305455200","article-title":"Ganglioside glycosyltransferases organize in distinct multienzyme complexes in CHO-K1 cells","volume":"278","author":"Giraudo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1073\/pnas.031458398","article-title":"Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the golgi apparatus","volume":"98","author":"Giraudo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2007.12.001_bib20","first-page":"2839","article-title":"The GM2 gangliosidoses","volume":"Vol. II","author":"Gravel","year":"1995"},{"key":"10.1016\/j.neuint.2007.12.001_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/bbrc.2000.4186","article-title":"Differential expression of three sialidase genes in rat development","volume":"280","author":"Hasegawa","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2007.12.001_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:BIGI.0000034429.55418.71","article-title":"Inheritance of lysosomal acid b-galactosidase activity and gangliosides in crosses of DBA\/2J and knockout mice","volume":"42","author":"Hauser","year":"2004","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/hmg\/6.11.1879","article-title":"Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay\u2013Sachs and Sandhoff diseases","volume":"6","author":"Huang","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib25","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.1073\/pnas.0500893102","article-title":"Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth","volume":"102","author":"Jennemann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2007.12.001_bib26","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2007.12.001_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V97.1.327","article-title":"Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation","volume":"97","author":"Jeyakumar","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.neuint.2007.12.001_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2990.2002.00422.x","article-title":"Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis","volume":"28","author":"Jeyakumar","year":"2002","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuint.2007.12.001_bib29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2007.12.001_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2007.12.001_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1471-4159.2004.02381.x","article-title":"N-Butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis","volume":"89","author":"Kasperzyk","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","article-title":"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice","volume":"46","author":"Kasperzyk","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2007.12.001_bib33","first-page":"472","article-title":"Miglustat. Oxford GlycoSciences\/Actelion","volume":"4","author":"Lachmann","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2007.12.001_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm1548","article-title":"Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease","volume":"13","author":"Lee","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2007.12.001_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","article-title":"A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder","volume":"103","author":"Liu","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2007.12.001_bib36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-2275(20)37906-2","article-title":"Analysis of brain lipids by high-performance thin-layer chromatography and densitometry","volume":"24","author":"Macala","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2007.12.001_bib37","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M609304200","article-title":"Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis","volume":"282","author":"Maegawa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.neuint.2007.12.001_bib39","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in GM1-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2007.12.001_bib40","series-title":"Basic Neurochemistry","first-page":"69","article-title":"Myelin formation, structure and biochemistry","author":"Morell","year":"1999"},{"key":"10.1016\/j.neuint.2007.12.001_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1098\/rstb.2003.1271","article-title":"Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease","volume":"358","author":"Moyses","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.neuint.2007.12.001_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/11.11.1343","article-title":"Molecular pathophysiology in Tay\u2013Sachs and Sandhoff diseases as revealed by gene expression profiling","volume":"11","author":"Myerowitz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib44","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, non-comparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuint.2007.12.001_bib45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2007.12.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","article-title":"Dramatically different phenotypes in mouse models of human Tay\u2013Sachs and Sandhoff diseases","volume":"5","author":"Phaneuf","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib47","series-title":"Lysosomal Disorders of the Brain","author":"Platt","year":"2004"},{"key":"10.1016\/j.neuint.2007.12.001_bib48","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1074\/jbc.272.31.19365","article-title":"Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin","volume":"272","author":"Platt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay\u2013Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuint.2007.12.001_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2007.12.001_bib51","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1098\/rstb.2003.1279","article-title":"Substrate reduction therapy in mouse models of the glycosphingolipidoses","volume":"358","author":"Platt","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.neuint.2007.12.001_bib52","first-page":"357","article-title":"Inhibitors and stimulators of glucocerebroside metabolism","volume":"95","author":"Radin","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.neuint.2007.12.001_bib53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0009-3084(70)90024-1","article-title":"The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion","volume":"5","author":"Roseman","year":"1970","journal-title":"Chem. Phys. Lipids"},{"issue":"Suppl.","key":"10.1016\/j.neuint.2007.12.001_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2008-1052387","article-title":"The biochemical basis of gangliosidoses","volume":"15","author":"Sandhoff","year":"1984","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuint.2007.12.001_bib55","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations and lipid storage in three variants of Tay\u2013Sachs disease","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib56","series-title":"The Metabolic Basis of Inherited Disease","first-page":"1807","article-title":"The GM2 gangliosidoses","author":"Sandhoff","year":"1989"},{"key":"10.1016\/j.neuint.2007.12.001_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00003495-200262050-00002","article-title":"New prospects for the treatment of lysosomal storage diseases","volume":"62","author":"Schiffmann","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.neuint.2007.12.001_bib59","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/BF00484350","article-title":"Heterosis for brain myelin content in mice","volume":"18","author":"Seyfried","year":"1980","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.1978.tb12428.x","article-title":"Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures","volume":"31","author":"Seyfried","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00484473","article-title":"Genetic variability for regional brain gangliosides in five strains of young mice","volume":"17","author":"Seyfried","year":"1979","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.neuint.2007.12.001_bib62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1471-4159.1982.tb08662.x","article-title":"Differential cellular enrichment of gangliosides in the mouse cerebellum: analysis using neurological mutants","volume":"38","author":"Seyfried","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.1983.tb04767.x","article-title":"Cellular localization of gangliosides in the developing mouse cerebellum: analysis using the weaver mutant","volume":"41","author":"Seyfried","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2007.12.001_bib64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0014-4886(84)90206-1","article-title":"Genetic analysis of cerebellar lipids in mice susceptible to audiogenic seizures","volume":"84","author":"Seyfried","year":"1984","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2007.12.001_bib65","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1523\/JNEUROSCI.3584-04.2004","article-title":"Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann\u2013Pick-A mouse leads to a marked decrease in lysosomal storage pathology","volume":"24","author":"Shihabuddin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2007.12.001_bib66","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.gt.3302033","article-title":"Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer","volume":"10","author":"Takaura","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuint.2007.12.001_bib67","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molcel.2004.08.029","article-title":"GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis","volume":"15","author":"Tessitore","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuint.2007.12.001_bib68","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/glycob\/10.12.1249","article-title":"Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases","volume":"10","author":"Tifft","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.neuint.2007.12.001_bib69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0387-7604(01)00216-9","article-title":"Galactonojirimycin derivatives restore mutant human beta-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse","volume":"23","author":"Tominaga","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuint.2007.12.001_bib70","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of \u03b2-hexosaminidase activity in fibroblasts from adult Tay\u2013Sachs and Sandhoff patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.12.001_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chembiol.2006.12.006","article-title":"High-throughput screening for human lysosomal beta-N-acetyl hexosaminidase inhibitors acting as pharmacological chaperones","volume":"14","author":"Tropak","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuint.2007.12.001_bib72","series-title":"Neurobiology of Cerebellar Evolution and Development","first-page":"859","article-title":"Some aspects of ontophylogenesis of the cerebellum","author":"Verbitskaya","year":"1969"},{"key":"10.1016\/j.neuint.2007.12.001_bib73","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2007.12.001_bib74","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1073\/pnas.0400625101","article-title":"Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018607003294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018607003294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T10:09:05Z","timestamp":1630318145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018607003294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0197018607003294"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2007.12.001","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}